Skip to content


Clinical research is the critical final step in making new technologies and treatments a reality for Australians living with T1D. The Australian T1D Clinical Research Network (CRN) accelerates this process and encourages collaboration and shared learning on an unprecedented scale.

In January 2019, the Federal Government announced their continued funding of the CRN, allowing us to continue to support researchers learn more about this condition and take us even closer to a world without type 1 diabetes. (3)


  • Bipartisan support for the continuation of the CRN, with $54.5 million in total funding committed by the Federal Government for type 1 diabetes, including $25 million for the CRN
  • More than $4.3M paid to CRN researchers in FY2019, across 25 research studies including 7 clinical trials
  • Findings from a JDRF-funded study show that the immunotherapy drug teplizumab can delay T1D diagnosis a median of 2 years in children and adults at high risk.


  • $350K with Macquarie Group Foundation for a world first study testing a fibre supplement in adults with T1D
  • 250+ researchers connected to the network
  • 70+ institutes connected
  • $29.4M in funding committed to clinical research, innovation and collaboration
  • Two next generation research leaders awarded fellowships
  • Environmental Determinants of Islet Autoimmunity (ENDIA) recruitment reaches 1000 participants
  • The Helmsley Charitable Trust awards almost $3M in funding towards two prevention projects
  • Almost $500K towards supporting translational research in Australia to bring new therapies to people sooner


  • More than 235 researchers now connected to the network
  • More than 65 institutes connected
  • $28M+ funding committed to clinical research, innovation and collaboration to progress research
  • $350K in seed funding for early research on innovative concepts
  • Launch of T1D Game Changer
  • ENDIA recruitment reaches over 700 participants


  • $4.5M committed to Innovation Awards - new directions to cure, treat and prevent T1D
  • More than 215 researchers connected to the network 
  • 63 institutes connected
  • $26M funding committed to clinical research, innovation and collaboration
  • Next generation research leaders awarded almost $2M


  • $14M in competitive grants allocated to five multi-state high impact clinical trials
  • 35 research institutions and universities connected to the network
  • More than 50 researchers supported in local jobs
  • ENDIA begins recruiting 1400 pregnant women and their infants 
  • The Australasian Diabetes Data Network (ADDN) builds from 4000 children in the Network to 6000 
  • 19 clinical centres joined four consortia in the areas of glucose control, prevention, complications and cure


  • The Federal Government commits a further $35M over five years
  • 43 key opinion leaders develop the research strategy and implementation plan
  • Major international partnership with US based Leona M. and Harry B. Helmsley Charitable Trust 
  • The Trust provides $4M towards the ENDIA  study


  • 100% of the $5M in funding is committed to research projects, talent and building the case for the future
  • Three large clinical trials
  • The formation of a unique national diabetes data network, the Australasian Diabetes Data Network (ADDN)
  • Nine Pilot and Feasibility projects awarded
  • Five Mentored Clinician Researcher Fellowships established, nurturing the next generation of researchers